Pomanda estimates the enterprise value of DR KERSHAW'S HOSPICE at £3.1m based on a Turnover of £5.8m and 0.53x industry multiple (adjusted for size and gross margin).
dr kershaw's hospiceEstimated Valuation
£7.3m
Pomanda estimates the enterprise value of DR KERSHAW'S HOSPICE at £7.3m based on an EBITDA of £1.8m and a 4.04x industry multiple (adjusted for size and gross margin).
dr kershaw's hospiceEstimated Valuation
£26.4m
Pomanda estimates the enterprise value of DR KERSHAW'S HOSPICE at £26.4m based on Net Assets of £11.9m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr Kershaw's HospiceOverview
Dr Kershaw's Hospice is a live company located in oldham, OL2 6EU with a Companies House number of 05221414. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2004, it's largest shareholder is
unknown.
Dr Kershaw's Hospice is a mature,
mid sized company, Pomanda has estimated its turnover at
£5.8m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Dr Kershaw'S Hospice a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
6 Strong
2 Regular
3 Weak
Size
annual sales of £5.8m, make it larger than the average company (£731.1k)
£5.8m - Dr Kershaw's Hospice
£731.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (7.2%)
10% - Dr Kershaw's Hospice
7.2% - Industry AVG
Production
with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)
38.4% - Dr Kershaw's Hospice
38.4% - Industry AVG
Profitability
an operating margin of 27.3% make it more profitable than the average company (5.2%)
27.3% - Dr Kershaw's Hospice
5.2% - Industry AVG
Employees
with 112 employees, this is above the industry average (18)
112 - Dr Kershaw's Hospice
18 - Industry AVG
Pay Structure
on an average salary of £33.9k, the company has a higher pay structure (£26.5k)
£33.9k - Dr Kershaw's Hospice
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £52.1k, this is equally as efficient (£45.8k)
£52.1k - Dr Kershaw's Hospice
£45.8k - Industry AVG
Debtor Days
it gets paid by customers after 46 days, this is later than average (20 days)
46 days - Dr Kershaw's Hospice
20 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (18 days)
4 days - Dr Kershaw's Hospice
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dr Kershaw's Hospice
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 668 weeks, this is more cash available to meet short term requirements (124 weeks)
668 weeks - Dr Kershaw's Hospice
124 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.7%, this is a lower level of debt than the average (22.7%)
1.7% - Dr Kershaw's Hospice
22.7% - Industry AVG
DR KERSHAW'S HOSPICE financials
EXPORT
Dr Kershaw'S Hospice's latest turnover from March 2024 is £5.8 million and the company has net assets of £11.9 million. According to their latest financial statements, Dr Kershaw'S Hospice has 112 employees and maintains cash reserves of £2.6 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
5,840,084
4,573,336
4,324,141
4,374,094
4,623,697
3,296,343
3,160,675
2,903,001
2,605,642
5,238,511
5,108,208
2,939,081
4,135,345
2,204,225
1,370,191
Other Income Or Grants
Cost Of Sales
3,596,416
2,849,798
2,750,784
2,875,214
2,954,879
2,142,783
1,989,159
1,771,441
1,626,092
3,262,328
3,170,326
1,773,388
2,379,621
1,239,357
776,442
Gross Profit
2,243,668
1,723,538
1,573,357
1,498,880
1,668,818
1,153,560
1,171,516
1,131,560
979,550
1,976,183
1,937,882
1,165,693
1,755,724
964,869
593,750
Admin Expenses
649,259
1,710,245
829,974
274,775
168,888
833,207
956,777
1,007,893
732,581
2,951,979
1,633,572
414,729
-532,071
62,086
-4,286,694
Operating Profit
1,594,409
13,293
743,383
1,224,105
1,499,930
320,353
214,739
123,667
246,969
-975,796
304,310
750,964
2,287,795
902,783
4,880,444
Interest Payable
Interest Receivable
27,178
24,396
22,221
16,076
10,266
4,532
Pre-Tax Profit
1,306,260
160,114
636,767
996,275
1,219,860
296,528
197,987
110,823
221,478
-948,618
328,706
773,184
2,303,870
913,049
4,884,976
Tax
-75,602
-185,564
-599,006
-255,654
-1,367,793
Profit After Tax
1,306,260
160,114
636,767
996,275
1,219,860
296,528
197,987
110,823
221,478
-948,618
253,104
587,620
1,704,864
657,395
3,517,183
Dividends Paid
Retained Profit
1,306,260
160,114
636,767
996,275
1,219,860
296,528
197,987
110,823
221,478
-948,618
253,104
587,620
1,704,864
657,395
3,517,183
Employee Costs
3,797,828
3,473,798
3,017,706
2,826,901
2,623,898
2,536,767
2,361,560
2,318,194
1,841,610
3,036,521
2,948,786
1,724,440
2,388,484
1,256,718
777,236
Number Of Employees
112
110
102
101
109
82
70
58
49
139
136
80
112
60
38
EBITDA*
1,813,237
205,354
925,391
1,260,775
1,499,930
337,559
352,503
263,397
392,872
-828,694
448,748
887,895
2,426,775
1,035,150
4,998,724
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
4,065,777
4,129,584
4,233,020
3,855,100
2,166,648
1,398,027
1,161,696
1,299,460
1,449,090
1,578,281
1,640,383
1,654,469
1,764,184
1,847,861
1,741,754
Intangible Assets
Investments & Other
3,951,879
3,111,906
32,223
31,880
31,880
33,968
34,621
36,198
35,686
36,400
34,301
33,750
32,298
29,900
28,579
Debtors (Due After 1 year)
Total Fixed Assets
8,017,656
7,241,490
4,265,243
3,886,980
2,198,528
1,431,995
1,196,317
1,335,658
1,484,776
1,614,681
1,674,684
1,688,219
1,796,482
1,877,761
1,770,333
Stock & work in progress
Trade Debtors
751,165
270,915
113,415
112,765
319,444
269,785
61,530
137,760
40,348
250,082
298,585
170,884
225,893
139,723
78,235
Group Debtors
41,652
57,779
74,757
58,781
35,271
123,024
107,000
84,399
61,268
Misc Debtors
619,979
351,207
519,350
1,799,887
1,994,731
281,045
119,088
76,633
70,946
Cash
2,623,595
2,986,734
5,689,910
5,709,936
6,017,898
6,121,308
6,073,630
5,802,188
6,087,492
5,863,966
5,007,037
4,751,534
4,136,723
2,293,575
1,812,793
misc current assets
total current assets
4,036,391
3,666,635
6,397,432
7,681,369
8,367,344
6,795,162
6,361,248
6,100,980
6,260,054
6,114,048
5,305,622
4,922,418
4,362,616
2,433,298
1,891,028
total assets
12,054,047
10,908,125
10,662,675
11,568,349
10,565,872
8,227,157
7,557,565
7,436,638
7,744,830
7,728,729
6,980,306
6,610,637
6,159,098
4,311,059
3,661,361
Bank overdraft
Bank loan
Trade Creditors
44,539
52,643
55,256
223,027
442,968
664,668
82,417
39,309
41,505
475,350
260,140
143,575
279,656
136,481
144,178
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
159,473
311,707
223,758
1,652,428
1,426,285
85,728
78,394
64,173
338,792
total current liabilities
204,012
364,350
279,014
1,875,455
1,869,253
750,396
160,811
103,482
380,297
475,350
260,140
143,575
279,656
136,481
144,178
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
204,012
364,350
279,014
1,875,455
1,869,253
750,396
160,811
103,482
380,297
475,350
260,140
143,575
279,656
136,481
144,178
net assets
11,850,035
10,543,775
10,383,661
9,692,894
8,696,619
7,476,761
7,396,754
7,333,156
7,364,533
7,253,379
6,720,166
6,467,062
5,879,442
4,174,578
3,517,183
total shareholders funds
11,850,035
10,543,775
10,383,661
9,692,894
8,696,619
7,476,761
7,396,754
7,333,156
7,364,533
7,253,379
6,720,166
6,467,062
5,879,442
4,174,578
3,517,183
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
1,594,409
13,293
743,383
1,224,105
1,499,930
320,353
214,739
123,667
246,969
-975,796
304,310
750,964
2,287,795
902,783
4,880,444
Depreciation
218,828
192,061
182,008
36,670
17,206
137,764
139,730
145,903
147,102
144,438
136,931
138,980
132,367
118,280
Amortisation
Tax
-75,602
-185,564
-599,006
-255,654
-1,367,793
Stock
Debtors
732,895
-27,621
-1,263,911
-378,013
1,675,592
386,236
-11,174
126,230
-77,520
-48,503
127,701
-55,009
86,170
61,488
78,235
Creditors
-8,104
-2,613
-167,771
-219,941
-221,700
582,251
43,108
-2,196
-433,845
215,210
116,565
-136,081
143,175
-7,697
144,178
Accruals and Deferred Income
-152,234
87,949
-1,428,670
226,143
1,340,557
7,334
14,221
-274,619
338,792
Deferred Taxes & Provisions
Cash flow from operations
920,004
318,311
592,861
1,644,990
943,195
540,908
421,006
-139,648
375,339
-564,981
362,010
621,259
1,884,774
710,311
3,696,874
Investing Activities
capital expenditure
-253,537
-17,050
-85,000
-130,352
-27,216
-55,303
-238,474
-1,860,034
Change in Investments
839,973
3,079,683
343
-2,088
-653
-1,577
512
-714
2,099
551
1,452
2,398
1,321
28,579
cash flow from investments
-839,973
-3,079,683
-343
2,088
-252,884
1,577
-512
-16,336
-87,099
-130,903
-28,668
-57,701
-239,795
-1,888,613
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
54,000
-2
-216,521
-134,389
-142,200
-110,324
1,481,831
interest
27,178
24,396
22,221
16,076
10,266
4,532
cash flow from financing
54,000
-2
-216,521
-134,389
-142,200
-110,324
1,509,009
24,396
22,221
16,076
10,266
4,532
cash and cash equivalents
cash
-363,139
-2,703,176
-20,026
-307,962
-103,410
47,678
271,442
-285,304
223,526
856,929
255,503
614,811
1,843,148
480,782
1,812,793
overdraft
change in cash
-363,139
-2,703,176
-20,026
-307,962
-103,410
47,678
271,442
-285,304
223,526
856,929
255,503
614,811
1,843,148
480,782
1,812,793
dr kershaw's hospice Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for dr kershaw's hospice. Get real-time insights into dr kershaw's hospice's credit score, group structure and payment trends.
Perform a competitor analysis for dr kershaw's hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in OL2 area or any other competitors across 12 key performance metrics.
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
September 2004
age
21
incorporated
UK
ultimate parent company
None
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
CHADWICK & CO (MANCHESTER ) LTD
address
dr kershaws hospice, turf lane royton, oldham, lancashire, OL2 6EU
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
dr kershaw's hospice Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to dr kershaw's hospice. Currently there are 1 open charges and 0 have been satisfied in the past.
dr kershaw's hospice Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR KERSHAW'S HOSPICE. This can take several minutes, an email will notify you when this has completed.
dr kershaw's hospiceCompanies House Filings - See Documents
